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A human liver cDNA library enriched for full-length clones was screened for plasminogen cDNA using 
a synthetic 24nucleotide probe derived from a reported partial cDNA sequence. 12 positive clones were 
identified and one of these was characterized in detail. The 2.7 kb insert contains the complete coding region. 
At 5 positions, it gives residues different from those reported in a previous amino acid sequence analysis 
of the protein. The present results show an extra IIe at position 65. Gln instead of Glu at positions 53 and 
342, Asn at position 88 instead of Asp, and Asp at position 453 rather than Asn. In the 3’-non-coding region 
an extension of 29 bases is found which does not contain any structure compatible with a known poly- 
adenylation signal. Instead, the consensus signal AATAAA is placed at a distance of 46 bases upstream 
of the poly(A)-tail. 
cDNA; Plasminogen; Plasma protein; (Human) 
1. INTRODUCTION 
The glycoprotein plasminogen is a zymogen in- 
volved in the final steps of fibrinolysis [l]. The 
amino acid sequence of human plasminogen has 
been determined [2-51. The one-chain proenzyme 
is converted to the active two-chain molecule 
plasmin by cleavage of the peptide bond between 
Arg-560 and Val-561 161. This specific cleavage is 
mediated by plasminogen activators, e.g. tissue 
piasminogen activator and urokinase. The serine 
protease function of the molecule is located in the 
carboxy-terminal part of the original protein (giv- 
ing the light chain after the activation cleavage). 
This region shows considerable amino acid se- 
quence homology with the serine proteases in- 
volved in blood coagulation, as well as those 
involved in other physiological processes uch as 
the digestive enzymes of the pancreas. 
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In the amino terminal part of the original 
molecule (the heavy chain) five tandem repeats, 
called kringles, are present. These structures, con- 
taining about 80 amino acids each are homologous 
to the two kringles present in the amino-terminal 
region of tissue plasminogen activator and pro- 
thrombin, as well as the single kringle present in 
the amino-terminal portion of urokinase and fac- 
tor XII of the blood coagulation (review [7]). The 
exact role of the kringles has not yet been 
elucidated, but at least in plasminogen and pro- 
thrombin some of the kringles have been shown to 
mediate fibrin binding. 
Based on the amino acid sequence homology 
between the serine proteases of coagulation and 
fibrinolysis Patthy [7,8] among others has pro- 
posed a hypothesis for the evolution of these en- 
zymes based on the assumption of exon-shuffling. 
To allow a more thorough and stringent com- 
parison of the different domains in these proteins 
knowledge of the complete nucleotide sequences of 
the respective genes and their genomic organiza- 
tion is essential. 
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Plasminogen, and many other enzymes in the 
coagulation and fibrinolysis systems, are synthe- 
sized in the liver. Recently a partial cDNA clone 
for plasminogen from human liver mRNA has 
been described [9]. In the present communication, 
a full-length cDNA clone for human plasminogen 
is reported. 
2. MATERIALS AND METHODS 
2.1. Restriction enzymes and isotopes 
Restriction enzymes, [cu-35S]dCTP (1100 Ci/ 
mmol), and [T-~~P]ATP (3000 Ci/mmol) were 
obtained from Amersham. 
2.2. Construction and isolation of cDNA clones 
In order to increase the probability to isolate a 
full-length cDNA clone for plasminogen, the 
method described by Okayama and Berg [lo,111 
was used with some modifications. The vector and 
linker fragments were both prepared from the 
plasmid pT4 (kindly provided by G. Gross, 
Gesellschaft fi,ir Biotechnologische Forschung, 
Braunschweig) as described in fig. 1. The use of the 
plasmid pT4 in preparing cDNA libraries has a 
great advantage in that the same vector can be used 
in the preparations of the vector and linker 
fragments, and inserts can easily be cleaved out. 
Some 10 bp downstream of the KpnI site there is 
a unique PstI site. Preparation of the linker frag- 
ment as outlined in fig. 1 will recreate the KpnI site. 
From 1 pg vector DNA and 5 pg human liver 
mRNA about 1.5 x 10’ transformants were ob- 
tained. The transformants were pooled and frozen 
in glycerol at - 70°C. From the published partial 
cDNA sequence [9], a 24-nucleotide probe was 
synthesized (121 and labelled with [32P]ATP as 
described [ 131. 
2.3. Plasmid DNA preparation and restriction 
enzyme analysis 
Plasmid DNA was isolated by density gradient 
centrifugation of cleared lysates [13] or by 
preparation of minilysates [ 141. Restriction en- 
zyme analysis of plasmid DNA was done as 
described [ 131. 
Agarose gel electrophoresis was done in 0.8% 
DNA grade agarose (Bio-Rad Laboratories) in 
Tris-acetate buffer [13], 100 V, at room 
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Fig. 1. Schematic description of the vector pT4 and the 
preparation of vector and linker fragments for cDNA 
cloning according to the Okayama-Berg procedure 
[ 10,111. Only restriction e zyme sites relevant to the text 
are indicated. 
temperature. Low gelling temperature agarose gels 
were run in the same buffer at +4”C. 
Transfer of restriction DNA fragments 
separated on agarose gel to nitrocellulose filter for 
hybridization was done by the Southern procedure 
u31. 
2.4. Nucleotide sequence determination 
Nucleotide sequence determination was done by 
the Sanger dideoxy chain-termination method [15] 
using 35S-labelled dCTP. Subcloning of ap- 
propriate restriction enzyme fragments in 
M13mp18 and M13mp19 was done by separating 
the DNA fragments on a 0.8% low gelling 
temperature agarose gel (Bio-Rad Laboratories) 
and subsequent ligation to the vectors as described 
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Table 1 
March 1987 
Oligonudeotide probe derived from the partial cDNA sequence [9] for the 
screening of the cDNA library 
292 299 
Amino acid sequence Ser- Gly- His- Thr- Cys- Gln- His- Trp 
DNA sequence 5 ’ - TCC GGG CAC ACC TGT CAG CAC TGG -3 ’ 
3’ - AGG CCC GTG TGG ACA GTC GTG ACC -5’ 
DNA probe 5’- TCC GGG CAC ACC TGT CAG CAC TGG -3’ 
The amino acid numbers given are with reference to the sequence in fig.4 
by Crouse et al. [16]. For confirmation of the 
DNA sequence around the restriction enzyme sites 
used in the subcloning, synthetic oligonucleotide 
primers were used. 
3. RESULTS 
About 1OooO transformants in the human liver 
cDNA Iibrary were screened for plasminogen 
clones were identified and, after rescreening, 
minilysates were analysed by agarose gel elec- 
trophoresis. One of the clones was chosen for a 
detailed analysis. An initial restriction enzyme 
analysis of plasmid DNA from this clone showed 
the size of the insert to be about 2.7 kb (fig.2A) 
which is a size expected for a fulI-length clone. 
Southern analysis (fig.2B) and DNA sequencing of 
fragments hybridizing to the oligonucleotide probe 
cDNA using a 32P-iabeiled o~gonuc~eotide probe con~rmed the presence of a 
(see table 1 for the sequence). Twelve positive sequence. For the complete 
A 8 
?aa~se7e 132 34 
Sire in bp 
1691 
plasminogen coding 
nucleotide sequence 
567a 
Fig.2. Restriction enzyme analysis and Southern analysis of the human plasm~ogen EDNA clone pPLGKG. Lanes 1 
and 8, pBR322 digested with WinfI as a molecular size marker. Lanes 2-7: pPLGKG digested with EcoRI (lane 2), 
BumHX (3), IrlpnI and P&I (4), PstI (5), KpnI (6), and Hind111 (7). (A) Ethidium bromide staining and (B) 
autoradiogram after hybridization with the DNA probe used for the colony hybridization. 
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Fig.3. Partial restriction enzyme map for the human plasminogen cDNA clone pPLGKG. Only restriction enzyme sites 
used in the DNA sequence determination are shown. The boxed region shows the coding part. The arrows represent 
subcloned fragments and the direction of the sequence determination. o----+ represents ynthetic primers. 
determination, restriction enzyme fragments were 
subcloned in Ml3 as outlined in fig.3. The DNA 
sequence was determined on both strands. For the 
5 ’ -.&WI-EcoRI and the 3 ’ -TagI-PstI fragments in- 
ternal synthetic oligonucleotide primers were used 
due to difficulties determining the sequence over 
the G/C and A/T tails. 
In fig.4 the compIete nucleotide sequence is 
presented. A 5 ’ -non-coding region of 64 bp is pre- 
sent and as most eukaryotic mRNA usually have a 
5 ‘-non-coding region ranging from 40 to 80 
nucleotides 1171 this indicates that the clone ob- 
tained may be of full length. The 253 bp 3 ‘-non- 
coding region is an extension by 29 bp in com- 
parison to the partial cDNA clone described by 
Malinowski et al. [9]. This extension does not con- 
tain a sequence known to function as a 
polyadenylation signal in eukaryotic mRNA [18]. 
A consensus AATAAA sequence is located at a 
position 46 nucleotides upstream of the 
polyadenylation site. The extension was further 
confirmed by sequencing using synthetic primers 
as indicated in figs 3 and 4. The coding region con- 
tains an amino-terminal sequence of 19 amino 
acids with the characteristics of a signal sequence 
u91. 
The sequence for the mature protein shows the 
presence of an extra isoleucine at position 85 
(fig.4) in comparison to the sequence published by 
Sottrup-Jensen et al. [5], giving a total of 791 
amino acids for human plasminogen. The present 
cDNA sequence deviates from the published amino 
acid sequence at the following positions as also 
observed by Malinowski et al. [9]: Cln instead of 
Glu at position 342 and Asp instead of Asn at posi- 
tion 453 (fig.4). Beside these discrepancies, the 
cDNA sequence now obtained predicts Gln instead 
of Glu at position 53 and Asn instead of Asp at 
position 88. The total amino acid composition of 
mature human plasminogen as well as the codon 
usage for the non-processed protein are given in 
tables 2 and 3, respectively. The calculated 
molecular mass for the processed non-glycosylated 
protein is 88400 Da, and for the heavy and the 
light chains 63200 and 25200 Da, respectively, as 
compared to an estimated 92 kDa for the 
glycosylated form and 57 and 25 kDa, respective- 
ly, for the heavy and light chains 1201. 
Table 2 
Total amino acid composition of mature plasminogen 
(the total number of amino acids is 791) 
Amino acid Number of residues Mel% 
Ala 36 4.55 
Arg 42 5.31 
Asn 39 4.93 
Asp 36 4.55 
GYs 48 6.07 
Gln 30 3.79 
Glu 54 6.83 
Gly 60 7.59 
His 23 2.91 
Ile 22 2.78 
Leu 42 5.31 
LYS 48 6.07 
Met 10 1.26 
Phe 20 2.53 
Pro 69 8.72 
Ser 55 6.95 
Thr 61 7.71 
Trp 19 2.40 
T yr 30 3.79 
Val 47 5.94 
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Fig.4. cDNA sequence for pPLGKG. The arrows * 
and t indicate the start of the mature protein and the 
site of cleavage of the proenzyme, respectively. Boxed 
amino acids represent amino acid deviations in 
comparison to the published amino acid sequence [5]. 
Underlining in the coding region of the DNA sequence 
indicates the segment used for preparation of the 
oiigonucleotide probe. w represents synthetic 
oligonucleotide primers. In the 3 ‘-non-coding region, 
the consensus poIyadenyIation site is undermined. 
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Table 3 
Codon usage for human plasminogen including the 
signal sequence 
Total number of amino acids 811 
Phe Ser Tyr CYS 
TTT 10 TCT 9 TAT 10 TCT 25 
TTC 11 TCC 20 TAC 20 TGC 23 
Leu TCA 10 stop stop 
TTA 3 TCG 0 TAA 1 TGA 0 
TTG 8 TAG 0 Trp 
TGG 19 
Leu Pro His Arg 
CTT 10 CCT 23 CAT 10 CGT 3 
CTC 5 ccc 16 CAC 14 CGC 6 
CTA 4 CCA 25 Gin CGA 3 
CTG 18 CCG 5 CAA 13 CGG 5 
CAG 18 
Be Thr Asn Ser 
ATT 9 ACT 16 AAT 22 AGT 11 
ATC 7 ACC 22 AAC 18 AGC 6 
ATA 6 ACA 19 LYS Arg 
Met ACG 4 AAA 22 AGA 10 
ATG 11 AAG 27 AGG 15 
Val Ala Asp GUY 
GTT 13 GCT 13 GAT 15 GGT 14 
GTC 12 GCC 11 GAC 21 GGC 11 
GTA 6 GCA 9 Glu GGA 24 
GTG 17 GCG 4 GAA 31 GGG 13 
GAG 25 
4. DISCUSSION 
The amino acid sequence for human 
plasminogen predicted from the nucleotide se- 
quence now presented shows the following 
discrepancies, besides those reported by 
Malinowski et al. [9], when compared to the se- 
quence published by Sottrup-Jensen et al. [5]: an 
extra Ile in the amino-terminal region of the 
mature protein, a Gln at position 53 instead of 
Glu, and Asn at position 88 instead of the reported 
Asp. The presence of the extra isoleucine residue 
can be explained by polymorphism or more likely 
by being overlooked in the protein sequencing 
since complete liberation of isoleucine, upon 
hydrolysis, can require extensive hydrolysis. All 
other deviations in the amino acid sequence are 
most likely due to difficulties in assignments of 
amidated or non-amidated forms of the amino 
acids in the protein sequence. However, in view of 
recent work [21] a polymorphism cannot be ruled 
out. The NMR studies on kringle 1 of human 
plasminogen which suggest discrepancies in the 
number of methionine, phenylalanine, tyrosine, 
and histidine residues [20] cannot be confirmed 
from the predicted amino acid sequence of the 
cDNA clone now isolated. For detection of any 
heterogeneity, in kringle 1 due to allelic variations, 
further analysis of cDNA clones from more human 
individuals are required in order for this to be 
determined. The now presented amino acid se- 
quence therefore essentially confirms the sequence 
presented by Sottrup-Jensen et al. [5]. 
Unlike many plasma proteins synthesized in the 
liver, human plasminogen does not seem to be syn- 
thesized with a pre-pro leader sequence. It is 
unlikely that the nucleotide sequence (fig.4) does 
not represent a full-length clone. The signal se- 
quence predicted from the DNA sequence is a 
strong argument for the presence of a full-length 
clone. 
The discrepancy in molecular mass found for the 
heavy chain is most likely due to the absence of the 
activation peptide in the heavy chain reported to 
have a molecular mass of 57 kDa. The overall 
codon usage is fairly random except that one 
codon, TCG for Ser, is not used at all. 
A polyadenylation signal (AATAAA) is general- 
ly found within 6-26 bases before the polyadenyla- 
tion site in most eukaryotic genes characterized so 
far [18]. Compared to the partial plasminogen 
cDNA described by Malinowski et al. [9] our clone 
contains an additional 29 bases at the 3’-end. No 
typical polyadenylation sequence is contained 
within these 29 bases. The consensus polyadenyla- 
tion sequence AATAAA is thus located 46 bases 
upstream from the poly-A tail. A variation in the 
length of the 3 ’ -non-coding region has been found 
previously, e.g. in cDNA clones corresponding to 
the P-subunit of alcohol dehydrogenase which 
were isolated from the same cDNA library [22]. 
Sadler et al. [23] have presented a partial 
genomic organization of kringles 4 and 5, and part 
of the light chain in human plasminogen. The 
cDNA clone for human plasminogen now 
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presented will facilitate isolation of genomic clones 
for a further characterization of the genomic 
organization of the human gene for plasminogen 
and its evolutionary relationship to other serine 
proteases. 
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